Tuesday, November 24, 2009

Multiple Sclerosis Home>
Multiple Sclerosis News>
Study: Only half of MS patients respond to interferon

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

Study: Only half of MS patients respond to interferon

(MedlinePlus) UPDATED 2008-11-12

Treating multiple sclerosis (MS) with the drug interferon only works in about half of patients who suffer from the disease, new research suggests. In the new study, scientists looked at brains scans of 15 MS patients who were given interferon every other day for nine months. Of these patients, only eight seemed to respond to the interferon treatment, showing a 60 percent reduction in their MS-related brain lesions. The other patients had varying degrees of reaction to the drug. Experts say this finding provides further evidence that MS is not just one disease, but rather a variety of diseases that doctors place under the umbrella of MS. Read full story >

See all Multiple Sclerosis News

Related: Interferon

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MultipleSclerosisCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.